Epidemiology of invasive candidiasis
The DOI matches its Crossref record; 211 of the 212 references it cites were found in a registry or an index.
Abstract
Purpose of review This review covers candidaemia in numbers, susceptibility issues, host groups, risk factors and outcome. Recent findings The incidence of candidaemia has increased over the last decades. Candida glabrata is particularly common in the northern hemisphere and with increasing age whilst the opposite is true for C. parapsilosis, C. glabrata, C. krusei and a number of emerging species are not fully susceptible to azoles. C. parapsilosis and C. guilliermondii are not fully susceptible to echinocandins. Increasing rates of C. parapsilosis have been observed at centres with a high use of echinocandins, and outcome for this species is not superior comparing echinocandins with fluconazole. Acquired azole resistance has recently been described in as many as a third of 19% resistant isolates and echinocandin resistance has emerged and been detected as early as day 12 of echinocandin therapy. ICU stay and abdominal surgery are among the most important risk factors. Outcome is dependent on species involved, timing, dosing and choice of therapy and management of the primary focus of infection. However, host factors are dominating predictors of mortality in recent studies of ICU candidiasis. Summary The changing epidemiology highlights the need for close monitoring of local incidence, species distribution and susceptibility in order to optimize therapy and outcome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Comparisons of the incidence across countries is difficult as recent local epidemiological data was only available for 20 of the countries and the others used an incidence of 5 per 100,000 cases for their estimations [46].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [46]
In the citing paper
“Specifically, C. glabrata has become an important pathogen in North America, Europe (with the exception of Spain), and Australia, whereas C. parapsilosis is the dominant non-albicans species in South America, Japan, and Spain [8,9,10].”
From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [9]
Citations
Cites
Guidelines for the Prevention of Intravascular Catheter-related Infections
O'Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,699
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
Vincent, J.-L. (2009) · JAMA · doi:10.1001/jama.2009.1754 · Cited by 3,618
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Research works printed but not linked: 3
- Hsin-Yun, 2010, Int J Antimicrob Agents, 353, 211
- Pfaller, 2007, J Invasive Fungal Infect, 1, 74
- Oxman, 2010, hemother, 65, 1460
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
“Comparisons of the incidence across countries is difficult as recent local epidemiological data was only available for 20 of the countries and the others used an incidence of 5 per 100,000 cases for their estimations [46].”
BackgroundKullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315
Self-citationBranzk, N., Lubojemska, A., Hardison, S. E., Wang, Q., Gutierrez, M. G., Brown, G. D., & Papayannopoulos, V. (2014) · Nature Immunology · doi:10.1038/ni.2987 · Cited by 1,037
Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance
Krcmery, V., & Barnes, A. J. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1151 · Cited by 733
Antifungal Resistance and New Strategies to Control Fungal Infections
Vandeputte, P., Ferrari, S., & Coste, A. T. (2012) · International Journal of Microbiology · doi:10.1155/2012/713687 · Cited by 505
Antifungal drug resistance among Candida species: mechanisms and clinical impact
Sanguinetti, M., Posteraro, B., & Lass‐Flörl, C. (2015) · Mycoses · doi:10.1111/myc.12330 · Cited by 394
Invasive candidiasis as a cause of sepsis in the critically ill patient
Delaloye, J., & Calandra, T. (2014) · Virulence · doi:10.4161/viru.26187 · Cited by 372
Epidemiology of candidemia in Latin America: a laboratory-based survey
Nucci, M., Queiroz-Telles, F., Alvarado-Matute, T., Tiraboschi, I. N., Cortes, J., Zurita, J., Guzman-Blanco, M., Santolaya, M. E., Thompson, L., Sifuentes-Osornio, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059373 · Cited by 374
Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis
Koehler, P., Stecher, M., Cornely, O. A., Koehler, D., Vehreschild, M. J. G. T., Bohlius, J., Wisplinghoff, H., & Vehreschild, J. J. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.024 · Cited by 336
Dadar, M., Tiwari, R., Karthik, K., Chakraborty, S., Shahali, Y., & Dhama, K. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.02.028 · Cited by 332
Candida Species Biofilms’ Antifungal Resistance
Silva, S., Rodrigues, C., Araújo, D., Rodrigues, M., & Henriques, M. (2017) · Journal of Fungi · doi:10.3390/jof3010008 · Cited by 302
Vargas, G., Rocha, J. D. B., Oliveira, D. L., Albuquerque, P. C., Frases, S., Santos, S. S., Nosanchuk, J. D., Gomes, A. M. O., Medeiros, L. C. A. S., Miranda, K., et al. (2015) · Cellular Microbiology · doi:10.1111/cmi.12374 · Cited by 295
Chang, K. C., Burnham, C.-A., Compton, S. M., Rasche, D. P., Mazuski, R., SMcDonough, J., Unsinger, J., Korman, A. J., Green, J. M., & Hotchkiss, R. S. (2013) · Critical Care · doi:10.1186/cc12711 · Cited by 281
Update on antifungal resistance in Aspergillus and Candida
Arendrup, M. C. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12513 · Cited by 240
Self-citationPfaller, M. A., Messer, S. A., Woosley, L. N., Jones, R. N., & Castanheira, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00308-13 · Cited by 237
National Surveillance of Fungemia in Denmark (2004 to 2009)
Arendrup, M. C., Bruun, B., Christensen, J. J., Fuursted, K., Johansen, H. K., Kjældgaard, P., Knudsen, J. D., Kristensen, L., Møller, J., Nielsen, L., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01811-10 · Cited by 223
Self-citationArendrup, M. C., Dzajic, E., Jensen, R. H., Johansen, H. K., Kjaldgaard, P., Knudsen, J. D., Kristensen, L., Leitz, C., Lemming, L. E., Nielsen, L., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12212 · Cited by 206
Self-citationMatsubara, V. H., Wang, Y., Bandara, H. M. H. N., Mayer, M. P. A., & Samaranayake, L. P. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7527-3 · Cited by 206
“Immunosuppressed individuals, transplant recipients, low-birth weight neonates, and patients under chemotherapy are more susceptible to invasive diseases caused by Candida, most often as bloodstream infections (candidaemia) with a risk to disseminate to different organs, such as the liver, spleen, bones, and heart (Ar…”
BackgroundResistance to antifungals that target CYP51
Parker, J. E., Warrilow, A. G. S., Price, C. L., Mullins, J. G. L., Kelly, D. E., & Kelly, S. L. (2014) · Journal of Chemical Biology · doi:10.1007/s12154-014-0121-1 · Cited by 204
Posteraro, B., De Pascale, G., Tumbarello, M., Torelli, R., Pennisi, M. A., Bello, G., Maviglia, R., Fadda, G., Sanguinetti, M., & Antonelli, M. (2011) · Critical Care · doi:10.1186/cc10507 · Cited by 185
Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia
Arendrup, M. C., Sulim, S., Holm, A., Nielsen, L., Nielsen, S. D., Knudsen, J. D., Drenck, N. E., Christensen, J. J., & Johansen, H. K. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00179-11 · Cited by 178
Self-citationEpidemiology and treatment approaches in management of invasive fungal infections
Ito, J. I., Kriengkauykiat, Dadwal, S., & Kriengkauykiat (2011) · Clinical Epidemiology · doi:10.2147/clep.s12502 · Cited by 203
FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia
Beyda, N. D., John, J., Kilic, A., Alam, M. J., Lasco, T. M., & Garey, K. W. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu407 · Cited by 174
Colombo, A. L., Guimarães, T., Camargo, L. F. A., Richtmann, R., de Queiroz-Telles, F., Salles, M. J. C., da Cunha, C. A., Yasuda, M. A. S., Moretti, M. L., & Nucci, M. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2013.02.001 · Cited by 153
Scorzoni, L., de Lucas, M. P., Mesa-Arango, A. C., Fusco-Almeida, A. M., Lozano, E., Cuenca-Estrella, M., Mendes-Giannini, M. J., & Zaragoza, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060047 · Cited by 150
Cacho, R. A., Jiang, W., Chooi, Y., Walsh, C. T., & Tang, Y. (2012) · Journal of the American Chemical Society · doi:10.1021/ja307220z · Cited by 145
Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region
Tan, T. Y., Hsu, L. Y., Alejandria, M. M., Chaiwarith, R., Chinniah, T., Chayakulkeeree, M., Choudhury, S., Chen, Y. H., Shin, J. H., Kiratisin, P., et al. (2016) · Medical Mycology · doi:10.1093/mmy/myv114 · Cited by 139
Interleukin-7 Ameliorates Immune Dysfunction and Improves Survival in a 2-Hit Model of Fungal Sepsis
Unsinger, J., Burnham, C.-A. D., McDonough, J., Morre, M., Prakash, P. S., Caldwell, C. C., Dunne, W. M., & Hotchkiss, R. S. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis383 · Cited by 131
MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyond
Posteraro, B., De Carolis, E., Vella, A., & Sanguinetti, M. (2013) · Expert Review of Proteomics · doi:10.1586/epr.13.8 · Cited by 128
T cells from patients with Candida sepsis display a suppressive immunophenotype
Spec, A., Shindo, Y., Burnham, C.-A. D., Wilson, S., Ablordeppey, E. A., Beiter, E. R., Chang, K., Drewry, A. M., & Hotchkiss, R. S. (2016) · Critical Care · doi:10.1186/s13054-016-1182-z · Cited by 128
Arendrup, M. C., Cuenca-Estrella, M., Lass-Flörl, C., & Hope, W. W. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2014.01.001 · Cited by 129
Self-citationVella, A., De Carolis, E., Vaccaro, L., Posteraro, P., Perlin, D. S., Kostrzewa, M., Posteraro, B., & Sanguinetti, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00903-13 · Cited by 124
Defining the frontiers between antifungal resistance, tolerance and the concept of persistence
Delarze, E., & Sanglard, D. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.10.001 · Cited by 118
“Candida albicans remains a major fungal pathogen in invasive diseases and is followed by several Candida spp. including C. glabrata, C. parapsilosis and C. tropicalis (Arendrup, 2010).”
BackgroundArendrup, M. C., Perlin, D. S., Jensen, R. H., Howard, S. J., Goodwin, J., & Hope, W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06369-11 · Cited by 117
“Candida glabrata is increasingly seen and is consistently the second most common Candida species in the Northern Hemisphere (2, 37).”
BackgroundSelf-citationTreatment of Invasive Candidiasis: A Narrative Review
Ben-Ami, R. (2018) · Journal of Fungi · doi:10.3390/jof4030097 · Cited by 111
Beyda, N. D., Lewis, R. E., & Garey, K. W. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1r020 · Cited by 109
Sugar Sensing and Signaling in Candida albicans and Candida glabrata
Van Ende, M., Wijnants, S., & Van Dijck, P. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00099 · Cited by 103
Colonization and epithelial adhesion in the pathogenesis of neonatal candidiasis
Bendel, C. M. (2003) · Seminars in Perinatology · doi:10.1016/s0146-0005(03)00059-4 · Cited by 105
Denning, D. W., Perlin, D. S., Muldoon, E. G., Colombo, A. L., Chakrabarti, A., Richardson, M. D., & Sorrell, T. C. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2302.152042 · Cited by 95
Strategies to Reduce Mortality in Adult and Neonatal Candidemia in Developing Countries
Kaur, H., & Chakrabarti, A. (2017) · Journal of Fungi · doi:10.3390/jof3030041 · Cited by 93
“The comorbidities for a higher risk of candidemia include acute necrotizing pancreatitis, haematological malignancies, solid organ tumours, neutropenia (<500/mm3), deteriorating clinical condition, chronic renal insufficiency and previous candidemia attacks [52,53].”
BackgroundDectin-1 Activation Controls Maturation of β-1,3-Glucan-containing Phagosomes
Mansour, M. K., Tam, J. M., Khan, N. S., Seward, M., Davids, P. J., Puranam, S., Sokolovska, A., Sykes, D. B., Dagher, Z., Becker, C., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.473223 · Cited by 85
Lindberg, E., Hammarström, H., Ataollahy, N., & Kondori, N. (2019) · Scientific Reports · doi:10.1038/s41598-019-40280-8 · Cited by 84
Savini, V., Catavitello, C., Onofrillo, D., Masciarelli, G., Astolfi, D., Balbinot, A., Febbo, F., D’Amario, C., & D’Antonio, D. (2011) · Mycoses · doi:10.1111/j.1439-0507.2010.01960.x · Cited by 84
Lohberger, A., Coste, A. T., & Sanglard, D. (2014) · Eukaryotic Cell · doi:10.1128/ec.00245-13 · Cited by 85
Stone, N. R. H., Gorton, R., Barker, K. R., Ramnarain, P., & Kibbler, C. C. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00028-13 · Cited by 83
Saccharomyces cerevisiae— a model to uncover molecular mechanisms for yeast biofilm biology
Bojsen, R. K., Andersen, K. S., & Regenberg, B. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00943.x · Cited by 91
Review of the Syntheses and Activities of Some Sulfur-Containing Drugs
Ferro, C. T. B., dos Santos, B. F., Silva, C. D. G., Brand, G., da Silva, C. D. G., & Domingues, N. L. C. (2020) · Current Organic Synthesis · doi:10.2174/1570179417666200212113412 · Cited by 81
Saliba, F., Pascher, A., Cointault, O., Laterre, P.-F., Cervera, C., De Waele, J. J., Cillo, U., Langer, R. M., Lugano, M., Göran-Ericzon, B., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1128 · Cited by 82
Rajendran, R., Sherry, L., Deshpande, A., Johnson, E. M., Hanson, M. F., Williams, C., Munro, C. A., Jones, B. L., & Ramage, G. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00915 · Cited by 81
Tadec, L., Talarmin, J., Gastinne, T., Bretonnière, C., Miegeville, M., Le Pape, P., & Morio, F. (2016) · Mycoses · doi:10.1111/myc.12470 · Cited by 80
Discovery of a Novel Class of Orally Active Antifungal β-1,3- d -Glucan Synthase Inhibitors
Walker, S. S., Xu, Y., Triantafyllou, I., Waldman, M. F., Mendrick, C., Brown, N., Mann, P., Chau, A., Patel, R., Bauman, N., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00432-11 · Cited by 75
“C. glabrata is frequently encountered in the clinic, causing as many as 20% of all candidemia cases in the United States and Canada (1).”
BackgroundInfluentialYang, S.-P., Chen, Y.-Y., Hsu, H., Wang, F., Chen, L.-Y., & Fung, C.-P. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-10 · Cited by 84
European expert opinion on the management of invasive candidiasis in adults
Kullberg, B. J., Verweij, P. E., Akova, M., Arendrup, M. C., Billé, J., Calandra, T., Cuenca‐Estrella, M., Herbrecht, R., Jacobs, F., Kalin, M., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03615.x · Cited by 78
Self-citationAnalysis of Candida auris fungemia at a single facility in Kenya
Adam, R. D., Revathi, G., Okinda, N., Fontaine, M., Shah, J., Kagotho, E., Castanheira, M., Pfaller, M. A., & Maina, D. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.06.001 · Cited by 72
Candidaemia in a European Paediatric University Hospital: a 10-year observational study
Tragiannidis, A., Fegeler, W., Rellensmann, G., Debus, V., Müller, V., Hoernig-Franz, I., Siam, K., Pana, Z. D., Jürgens, H., & Groll, A. H. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03720.x · Cited by 72
Shi, W., Chen, Z., Chen, X., Cao, L., Liu, P., & Sun, S. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00664.x · Cited by 71
Miyazaki, T., Inamine, T., Yamauchi, S., Nagayoshi, Y., Saijo, T., Izumikawa, K., Seki, M., Kakeya, H., Yamamoto, Y., Yanagihara, K., et al. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00611.x · Cited by 70
Sun, Y., Yu, S., Sun, P., Wu, H., Zhu, W., Liu, W., Zhang, J., Fang, J., & Li, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040629 · Cited by 74
Structural basis for promiscuity and specificity during Candida glabrata invasion of host epithelia
Maestre-Reyna, M., Diderrich, R., Veelders, M. S., Eulenburg, G., Kalugin, V., Brückner, S., Keller, P., Rupp, S., Mösch, H.-U., & Essen, L.-O. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207653109 · Cited by 67
Taira, C. L., Okay, T. S., Delgado, A. F., Ceccon, M. E. J. R., de Almeida, M. T. G., & Negro, G. M. B. D. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-406 · Cited by 71
Taj‐Aldeen, S. J., Kolecka, A., Boesten, R., Alolaqi, A., Almaslamani, M., Chandra, P., Meis, J. F. G. M., & Boekhout, T. (2013) · Infection · doi:10.1007/s15010-013-0570-4 · Cited by 81
Carolis, E. D., Vella, A., Vaccaro, L., Torelli, R., Posteraro, P., Ricciardi, W., Sanguinetti, M., & Posteraro, B. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03355-13 · Cited by 73
Riera, F. O., Caeiro, J. P., Angiolini, S. C., Vigezzi, C., Rodriguez, E., Icely, P. A., & Sotomayor, C. E. (2022) · Antibiotics · doi:10.3390/antibiotics11070877 · Cited by 65
“Table 1 summarizes the antifungal drugs used for the clinical management of invasive candidiasis, categorized as primary and alternative, including recently introduced new drugs [98,99].”
BackgroundPfaller, M. A., Messer, S. A., Jones, R. N., & Castanheira, M. (2015) · The Journal of Antibiotics · doi:10.1038/ja.2015.29 · Cited by 64
Molecular Methods for the Diagnosis of Invasive Candidiasis
Camp, I., Spettel, K., & Willinger, B. (2020) · Journal of Fungi · doi:10.3390/jof6030101 · Cited by 75
A complex game of hide and seek: the search for new antifungals
Ngo, H., Garneau‐Tsodikova, S., & Green, K. D. (2016) · MedChemComm · doi:10.1039/c6md00222f · Cited by 82
Candidemia in the Intensive Care Unit
Epelbaum, O., & Chasan, R. (2017) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2017.04.010 · Cited by 78
Designing a new antifungal glycoconjugate vaccine
Johnson, M. A., & Bundle, D. R. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35382b · Cited by 69
Burden of serious fungal infection in Nigeria.
(2014) · PubMed · Cited by 62
Kasper, L., Seider, K., Gerwien, F., Allert, S., Brunke, S., Schwarzmüller, T., Ames, L., Zubiria-Barrera, C., Mansour, M. K., Becken, U., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096015 · Cited by 59
Vatanshenassan, M., Boekhout, T., Lass‐Flörl, C., Lackner, M., Schubert, S., Kostrzewa, M., & Sparbier, K. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00420-18 · Cited by 68
Rosenvinge, F. S., Dzajic, E., Knudsen, E., Malig, S., Andersen, L. B., Løvig, A., Arendrup, M. C., Jensen, T. G., Gahrn‐Hansen, B., & Kemp, M. (2012) · Mycoses · doi:10.1111/myc.12000 · Cited by 63
Self-citationDiab-Elschahawi, M., Forstner, C., Hagen, F., Meis, J. F., Lassnig, A. M., Presterl, E., & Klaassen, C. H. W. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01179-12 · Cited by 57
Amarsy, R., Trystram, D., Cambau, E., Monteil, C., Fournier, S., Oliary, J., Junot, H., Sabatier, P., Porcher, R., Robert, J., et al. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.10.034 · Cited by 67
de Melo, A. P. V., Zuza-Alves, D. L., Rocha, W. P. D. S., de Souza, L. B. F. C., Francisco, E. C., Melo, A. S. D. A., & Chaves, G. M. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.02.002 · Cited by 62
Wijesinghe, G. K., Maia, F. C., de Oliveira, T. R., de Feiria, S. N. B., Jóia, F., Barbosa, J. P., Boni, G. C., Sardi, J. D. C. O., Rosalen, P. L., & Höfling, J. F. (2020) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760200349 · Cited by 63
Faria‐Ramos, I., Neves-Maia, J., Ricardo, E., Santos‐Antunes, J., Silva, A. P., Costa‐de‐Oliveira, S., Cantón, R., Rodrigues, A. G., & Pina‐Vaz, C. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2194-8 · Cited by 69
Antifungal drug resistance in Candida: a special emphasis on amphotericin B
Ahmady, L., Gothwal, M., Mukkoli, M. M., & Bari, V. K. (2024) · Apmis · doi:10.1111/apm.13389 · Cited by 65
Ericson, E.-L., Klingspor, L., Ullberg, M., & Özenci, V. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.02.020 · Cited by 55
Saraçlı, M. A., Fothergill, A. W., Sutton, D. A., & Wiederhold, N. P. (2015) · Medical Mycology · doi:10.1093/mmy/myv046 · Cited by 65
Al-Mulla, Z., & Christensen, R. D. (1995) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30277-x · Cited by 57
Savage, K. A., Parquet, M. D. C., Allan, D. S., Davidson, R. J., Holbein, B. E., Lilly, E. A., & Fidel, P. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02576-17 · Cited by 53
“predisposing host factors are implicated in infection (12).”
BackgroundSelective BET bromodomain inhibition as an antifungal therapeutic strategy
Mietton, F., Ferri, E., Champleboux, M., Zala, N., Maubon, D., Zhou, Y., Harbut, M., Spittler, D., Garnaud, C., Courçon, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15482 · Cited by 52
Desai, C., Mavrianos, J., & Chauhan, N. (2011) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2011.00743.x · Cited by 52
de Barros, P. P., Scorzoni, L., Ribeiro, F. D. C., Fugisaki, L. R. D. O., Fuchs, B. B., Mylonakis, E. E., Jorge, A. O. C., Junqueira, J. C., & Rossoni, R. D. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.02.019 · Cited by 60
Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008–2018
Won, E. J., Choi, M. J., Kim, M., Yong, D., Lee, W. G., Uh, Y., Kim, T. S., Byeon, S. A., Lee, S. Y., Kim, S. H., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2703.203482 · Cited by 59
Holbrook, S. Y. L., Garzan, A., Dennis, E. K., Shrestha, S. K., & Garneau-Tsodikova, S. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.07.030 · Cited by 51
Jawhara, S., Mogensen, E., Maggiotto, F., Fradin, C., Sarazin, A., Dubuquoy, L., Maes, E., Guérardel, Y., Janbon, G., & Poulain, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.329300 · Cited by 51
Burden of Fungal Infections in Colombia
Álvarez, C., Cortés, J. A., & Denning, D. W. (2018) · Journal of Fungi · doi:10.3390/jof4020041 · Cited by 57
Interesting antifungal drug targets in the central metabolism of Candida albicans
Wijnants, S., Vreys, J., & Dijck, P. V. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.10.003 · Cited by 54
Bonfietti, L. X., Martins, M. D. A., Szeszs, M. W., Pukinskas, S. R. B. S., Purisco, S. U., Pimentel, F. C., Pereira, G. H., Silva, D. C., de Oliveira, L., & Melhem, M. D. S. C. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.037812-0 · Cited by 57
Diagnosis of Invasive Candidiasis: From Gold Standard Methods to Promising Leading-edge Technologies
Pitarch, A., Nombela, C., & Gil, C. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666181025093146 · Cited by 56
Chew, S. Y., Ho, K. L., Cheah, Y. K., Ng, T. S., Sandai, D., Brown, A. J. P., & Than, L. T. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-39117-1 · Cited by 49
Tsai, Y., & Hwang, T. (2015) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2015.1061998 · Cited by 57
Estimated Burden of Serious Fungal Infections in Ghana
Ocansey, B. K., Pesewu, G. A., Codjoe, F. S., Osei-Djarbeng, S. N., Feglo, P. K., & Denning, D. W. (2019) · Journal of Fungi · doi:10.3390/jof5020038 · Cited by 54
Krčméry, V., & Kovacicova, G. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00096-6 · Cited by 56
Burden of serious fungal infections in Mexico
Corzo‐León, D. E., Armstrong‐James, D., & Denning, D. W. (2015) · Mycoses · doi:10.1111/myc.12395 · Cited by 48
A 5-Year Review of Invasive Fungal Infection at an Academic Medical Center
Li, Y., Gao, Y., Niu, X., Wu, Y., Du, Y., Yang, Y., Qi, R., Chen, H., Gao, X., Song, B., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.553648 · Cited by 51
Incidence and outcome of fungal infections in pediatric small bowel transplant recipients
Florescu, D. F., Islam, K. M. M., Grant, W., Mercer, D. F. F., Langnas, A. N., Botha, J. F., Nielsen, B., & Kalil, A. C. (2010) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2010.00542.x · Cited by 48
Of mice, flies – and men? Comparing fungal infection models for large-scale screening efforts
Brunke, S., Quintin, J., Kasper, L., Jacobsen, I. D., Richter, M. E., Hiller, E., Schwarzmüller, T., d'Enfert, C., Kuchler, K., Rupp, S., et al. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.019901 · Cited by 47
Metadata
- Authors
- Arendrup, M. C.
- Affiliations
- Statens Serum Institut (DK)
- Corresponding author
- Arendrup, Maiken C
- ORCID
- Arendrup, Maiken C
- Venue
- Current Opinion in Critical Care
- Published
- 2010-10
- Volume
- 16
- Issue
- 5
- Pages
- 445-452
- ISSN
- 1070-5295 (ISSN-L)
- OpenAlex
- W2088977070
- Cited by
- 376
- References
- 212
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 12 · 2023: 15 · 2022: 14 · 2021: 24 · 2020: 30 · 2019: 25 · 2018: 35 · 2017: 27 · 2016: 24 · 2015: 33 · 2014: 27 · 2013: 35 · 2012: 32
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Critical Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Astellas Pharma
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- invasive candidiasis, candidemia, Candida parapsilosis, Candida glabrata, Candida krusei, Candida guilliermondii, antifungal susceptibility, azole resistance, echinocandin resistance, fluconazole, risk factors, mortality, intensive care unit, abdominal surgery, antifungal therapy
- MeSH terms
- Disease Susceptibility, Humans, Intensive Care Units, Species Specificity, Candidiasis, Invasive, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.